SCHEMBL10001413

SCHEMBL10001413

CNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 10/20 1.00
ADORA2B P29275 6/20 1.00
ADORA1 P30542 5/20 1.00
HSP90B1 P14625 5/20 1.00
TSHR P16473 4/20 1.00
ADORA2A P29274 4/20 1.00
HSP90AA1 P07900 3/20 1.00
KMT2A Q03164 2/20 1.00
AHCY P23526 2/20 1.00
LMNA P02545 1/20 1.00
THRB P10828 1/20 1.00
BLM P54132 1/20 1.00
MAPK1 P28482 2/20 0.78
RXFP1 Q9HBX9 2/20 0.78
CYP2C19 P33261 1/20 0.78
TMIGD3 P0DMS9 1/20 0.78
MEN1 O00255 1/20 0.78
CYP2C9 P11712 1/20 0.78
HRH1 P35367 1/20 0.75
TMEM97 Q5BJF2 1/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12119006 1.00 ADORA3 (1.00) ADORA3ADORA2BADORA1HSP90B1TSHR
SCHEMBL8373480 0.91 ADORA3 (0.85) ADORA3ADORA2BADORA1HSP90B1TSHR
Neca SCHEMBL29361791 0.88 TSHR (1.00) ADORA3ADORA2BADORA1HSP90B1TSHR
Neca SCHEMBL30656108 0.88 TSHR (1.00) ADORA3ADORA2BADORA1HSP90B1TSHR
Neca SCHEMBL30036568 0.88 TSHR (1.00) ADORA3ADORA2BADORA1HSP90B1TSHR
Neca SCHEMBL19928417 0.88 TSHR (1.00) ADORA3ADORA2BADORA1HSP90B1TSHR
Neca SCHEMBL16585523 0.88 TSHR (1.00) ADORA3ADORA2BADORA1HSP90B1TSHR
Neca SCHEMBL18089301 0.88 TSHR (1.00) ADORA3ADORA2BADORA1HSP90B1TSHR
Neca SCHEMBL19928418 0.88 TSHR (1.00) ADORA3ADORA2BADORA1HSP90B1TSHR
Neca SCHEMBL12119012 0.88 TSHR (1.00) ADORA3ADORA2BADORA1HSP90B1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020165432-A1 3,6-DISUBSTITUTED-2-PYRIDINALDOXIME SCAFFOLDS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2020-08-20 WO disclosed
US-8158376-B2 Bisubstrate fluorescent probe binding to protein kinases UNIVERSITY OF TARTU (EE) 2012-04-17 US disclosed
US-20100233743-A1 BISUBSTRATE FLUORESCENT PROBE BINDING TO PROTEIN KINASES UNIVERSITY OF TARTU (EE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100233743-A1 BISUBSTRATE FLUORESCENT PROBE BINDING TO PROTEIN KINASES ADK, PRKCH, DMPK ADORA3 425/4885ADORA2B 713/4885ADORA1 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.